Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2000-09-27
2002-06-18
McKane, Joseph K. (Department: 1626)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
C548S502000
Reexamination Certificate
active
06407261
ABSTRACT:
This invention relates to a process for preparing certain 4-hydroxy indole, indazole and 4-hydroxy carbozole compounds useful as intermediates for preparing compounds useful for inhibiting sPLA
2
mediated release of fatty acids for conditions such as septic shock.
Certain 1H-indole-3-glyoxamides are known to be potent and selective inhibitors of mammalian sPLA
2
useful for treating diseases, such as septic shock, adult respiratory distress syndrome, pancreatitis, trauma, bronchial asthma, allergic rhinitis, rheumatoid arthritis and related sPLA
2
induced diseases. EPO publication No. 0675110, for example, discloses such compounds.
Various patents and publications describe processes for making these compounds using 4-hydroxy indole intermediates.
The article, “Recherches en serie indolique. VI sur tryptamines substituees”, by Marc Julia, Jean Igolen and Hanne Igolen, Bull. Soc. Chim. France, 1962, pp. 1060-1068, describes certain indole-3-glyoxylamides and their conversion to tryptamine derivatives.
The article, “2-Aryl-3-Indoleglyoxylamides (FGIN-1): A New Class of Potent and Specific Ligands for the Mitochondrial DBI Receptor (MDR)” by E. Romeo, et al., The Journal of Pharmacology and Experimental Therapeutics, Vol. 262, No. 3, (pp. 971-978) describes certain 2-aryl-3-indolglyoxylamides having research applications in mammalian central nervous systems.
The abstract, “Fragmentation of N-benzylindoles in Mass Spectrometry”; Chemical Abstracts, Vol. 67, 1967, 73028h, reports various benzyl substituted phenols including those having glyoxylamide groups at the 3 position of the indole nucleus.
U.S. Pat. No. 3,449,363 describes trifluoromethylindoles having glyoxylamide groups at the 3 position of the indole nucleus.
U.S. Pat. No. 3,351,630 describes alpha-substituted 3-indolyl acetic acid compounds and their preparation inclusive of glyoxylamide intermediates.
U.S. Pat. No. 2,825,734 describes the preparation of 3-(2-amino-1-hydroxyethyl)indoles using 3-indoleglyoxylamide intermediates such as 1-phenethyl-2-ethyl-6-carboxy-N-propyl-3-indoleglyoxylamide (see, Example 30).
U.S. Pat. No. 4,397,850 prepares isoxazolyl indolamines using glyoxylamide indoles as intermediates.
U.S. Pat. No. 3,801,594 describes analgesics prepared using 3-indoleglyoxylamide intermediates.
The article, “No. 565.—Inhibiteurs d'enzymes. XII.—Preparation de (propargylamino-2 ethyl)-3 indoles” by A. Alemanhy, E. Fernandez Alvarez, O. Nieto Lopey and M. E. Rubic Herraez; Bulletin De La Societe Chimique De France, 1974, No. 12, pp. 2883-2888, describes various indolyl-3 glyoxamides which are hydrogen substituted on the 6-membered ring of the indole nucleus.
The article “Indol-Umlagerung von 1-Diphenylamino-2,3-dihydro-2,3-pyrrolidonen” by Gert Kollenz and Christa Labes; Liebigs Ann. Chem., 1975, pp. 1979-1983, describes phenyl substituted 3-glyoxylamides.
Many of these processes employ a 4-hydroxy indole intermediate. For example U.S. Pat. No. 5,654,326 U.S., herein incorporated by reference in its entirety, discloses a process for preparing 4-substituted-1H-indole-3-glyoxamide derivatives comprising reacting an appropriately substituted 4-methoxyindole (prepared as described by Clark, R. D. et al., Synthesis, 1991, pp 871-878, the disclosures of which are herein incorporated by reference) with sodium hydride in dimethylformamide at room temperature (20-25° C.) then treating with arylmethyl halide at ambient temperatures to give the 1-arylmethylindole which is O-demethylated using boron tribromide in methylene chloride (Tsung-Ying Shem and Charles A. Winter, Adv. Drug Res., 1977, 12, 176, the disclosure of which is incorporated by reference) to give the 4-hydroxyindole. Alkylation of the hydroxy indole is achieved with an alpha bromoalkanoic acid ester in dimethylformamide using sodium hydride as a base. Conversion to the glyoxamide is achieved by reacting the ∝-[(indol-4-yl)oxy]alkanoic acid ester first with oxalyl chloride, then with ammonia, followed by hydrolysis with sodium hydroxide in methanol.
The process for preparing 4-substituted-1H-indole-3-glyoxamide derivatives, as set forth above, has utility. However, this process uses expensive reagents and environmentally hazardous organic solvents, produces furan containing by-products and results in a relatively low yield of desired product.
In an alternate preparation an appropriately substituted propronylacetate is halogenated with sulfuryl chloride. The halogenated Intermediate is hydrolyzed and decarboxylated by treatment with hydrochloric acid then reacted with an appropriately substituted cyclohexane dione. Treatment of the alkylated dione with an appropriate amine affords a 4-keto-indole which is oxidized by refluxing in a high-boiling polar hydrocarbon solvent such as carbitol in the presence of a catalyst, such as palladium on carbon, to prepare the 4-hydroxyindole which may then be alkylated and converted to the desired glyoxamide as described above.
This process however is limited by the required high temperature oxidation and requires recovery of a precious metal catalyst.
While the methods described above for preparing the 4-hydroxy indole intermediate are satisfactory, a more efficient transformation is desirable.
The present invention provides an improved process for preparing 4-hydroxy-indole intermediates. The process of the present invention can be performed with inexpensive, readily available, reagents under milder conditions. In addition, the present process allows for transformation with a wider variety of substituents on the indole platform. Other objects, features and advantages of the present invention will become apparent from the subsequent description and the appended claims.
The present invention provides a process for preparing a compound of the formula I
wherein:
Y is —CR
4
or —N—;
R
4
is H, —(C
1
-C
6
)alkyl or when taken together with R
2
forms a cyclohexeny ring
R
2
is non-interfering substituent;
R
3
is a non-interfering substituent;
m is 1-3 both inclusive; and
R
1
is selected from groups (a), (b) and (c) where;
(a) is —(C
1
-C
20
)alkyl, —(C
2
-C
20
)alkenyl, —(C
2
-C
20
)alkynyl, carbocyclic radicals, or heterocyclic radicals, or
(b) is a memeber of (a) substituted with one or more independently selected non-interfering substituents; or
(c) is the group —(L)—R
80
); where, (L)— is a divalent linking group of 1 to 12 atoms selected from carbon, hydrogen, oxygen, nitrogen, and sulfur; wherein the combination of atoms in —(L)— are selected from the group consisting of (i) carbon and hydrogen only, (ii) one sulfur only, (iii) one oxygen only, (iv) one or two nitrogen and hydrogen only, (v) carbon, hydrogen, and one sulfur only, and (vi) an carbon, hydrogen, and oxygen only; and where R
80
is a group selected from (a) or (b);
which process comprises oxidizing a compound of formula III
by heating with a base and a compound of the formula
where R is —(C
1
-C
6
)alkyl or aryl and X is —(C
1
-C
6
)alkoxy, halo or —OCO
2
(C
1
-C
6
)alkyl.
The invention provides in addition novel reagents of the formula
where R is —(C
1
-C
6
)alkyl, aryl or substituted aryl; and
X is —OCO
1
(C
1
-C
6
)alkyl provided that when X is —OCO
2
CH
3
, R cannot be tolulyl.
The present invention provides, in addition novel intermediates of the formula
wherein:
R is —(C1-C6)alkyl, aryl or substituted aryl,
Y is —CR
4
or —N—;
R
4
is H, —(C
1
-C
6
)alkyl or when taken together with R
2
forms a cyclohexeny ring
R
2
is non-interfering substituent;
R
3
is a non-interfering substituent;
m is 1-3; and
R
1
is selected from groups (a), (b) and (c) where;
(a) is —(C
1
-C
20
)alkyl, —(C
2
-C
20
)alkenyl, —(C
2
-C
20
,)alkynyl, carbocyclic radicals, or heterocyclic radicals, or
(b) is a memeber of (a) substituted with one or more independently selected non-interfering substituents; or
(c) is the group —(L)—R
80
; where, (L)— is a divalent linking group of 1 to 12 atoms selected from carbon, hydrogen, oxygen, nitrogen, and sulfur; wherein the combination of atoms in —(L)— are selected from the group consisting of (i) carbon and hy
Anderson Benjamin Alan
Harn Nancy Kay
Eli Lilly and Company
Ginah Francis O.
McKane Joseph K.
Palmberg Arleen
Wright Sonya
LandOfFree
Process for preparing 4-hdyroxy indole, indazole and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Process for preparing 4-hdyroxy indole, indazole and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Process for preparing 4-hdyroxy indole, indazole and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2965259